Imperial College London

ProfessorNickHopkinson

Faculty of MedicineNational Heart & Lung Institute

Professor of Respiratory Medicine
 
 
 
//

Contact

 

n.hopkinson

 
 
//

Location

 

Muscle LabSouth BlockRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Philip:2022:10.1136/bmjresp-2021-001056,
author = {Philip, K and Buttery, S and Williams, P and Vijayakumar, B and Tonkin, J and Cumella, A and Lottie, R and Ogden, L and Quint, J and Johnston, S and Polkey, M and Hopkinson, N},
doi = {10.1136/bmjresp-2021-001056},
journal = {BMJ Open Respiratory Research},
title = {Impact of COVID-19 on people with asthma: A mixed methods analysis from a UK wide survey},
url = {http://dx.doi.org/10.1136/bmjresp-2021-001056},
volume = {9},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Introduction: The impact of acute COVID-19 on people with asthma appears complex, being moderated by multiple interacting disease-specific, demographic and environmental factors. Research regarding longer-term effects in this group is limited. We aimed to assess impacts of COVID-19 and predictors of persistent symptoms, in people with asthma.Methods: Using data from an online UK-wide survey of 4500 people with asthma (median age 50–59 years, 81% female), conducted in October 2020, we undertook a mixed methods analysis of the characteristics and experience of those reporting having had COVID-19.Results: The COVID-19 group (n=471, 10.5%) reported increased inhaler use and worse asthma management, compared with those not reporting COVID-19, but did not differ by gender, ethnicity or household income. Among the COVID-19 group, 56.1% reported having long COVID, 20.2% were ‘unsure’. Those with long COVID were more likely than those without long COVID to describe: their breathing as worse or much worse after their initial illness (73.7% vs 34.8%, p<0.001), increased inhaler use (67.8% vs 34.8%, p<0.001) and worse or much worse asthma management (59.6% vs 25.6%, p<0.001). Having long COVID was not associated with age, gender, ethnicity, UK nation or household income.Analysis of free text survey responses identified three key themes: (1) variable COVID-19 severity, duration and recovery; (2) symptom overlap and interaction between COVID-19 and asthma; (3) barriers to accessing healthcare.Conclusions: Persisting symptoms are common in people with asthma following COVID-19. Measures are needed to ensure appropriate healthcare access including clinical evaluation and investigation, to distinguish between COVID-19 symptoms and asthma.
AU - Philip,K
AU - Buttery,S
AU - Williams,P
AU - Vijayakumar,B
AU - Tonkin,J
AU - Cumella,A
AU - Lottie,R
AU - Ogden,L
AU - Quint,J
AU - Johnston,S
AU - Polkey,M
AU - Hopkinson,N
DO - 10.1136/bmjresp-2021-001056
PY - 2022///
SN - 2052-4439
TI - Impact of COVID-19 on people with asthma: A mixed methods analysis from a UK wide survey
T2 - BMJ Open Respiratory Research
UR - http://dx.doi.org/10.1136/bmjresp-2021-001056
UR - http://hdl.handle.net/10044/1/93657
VL - 9
ER -